Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway
This research investigated if pitavastatin (Pita) might protect rats’ kidneys against thioacetamide (TAA). By altering the PTEN/AKT/mTOR pathway, pitavastatin may boost kidney antioxidant capacity and minimize oxidative damage. Statins have several benefits, including antioxidant and anti-inflammato...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Advances in Pharmacological and Pharmaceutical Sciences |
Online Access: | http://dx.doi.org/10.1155/2024/6681873 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832559586021736448 |
---|---|
author | Marawan A. Elbaset Bassim M. S. A. Mohamed Passant E. Moustafa Tuba Esatbeyoglu Sherif M. Afifi Alyaa F. Hessin Sahar S. Abdelrahman Hany M. Fayed |
author_facet | Marawan A. Elbaset Bassim M. S. A. Mohamed Passant E. Moustafa Tuba Esatbeyoglu Sherif M. Afifi Alyaa F. Hessin Sahar S. Abdelrahman Hany M. Fayed |
author_sort | Marawan A. Elbaset |
collection | DOAJ |
description | This research investigated if pitavastatin (Pita) might protect rats’ kidneys against thioacetamide (TAA). By altering the PTEN/AKT/mTOR pathway, pitavastatin may boost kidney antioxidant capacity and minimize oxidative damage. Statins have several benefits, including antioxidant and anti-inflammatory characteristics. The principal hypothesis of this study was that Pita can regulate the miR-93/PTEN/AKT/mTOR pathways, which is thought to be responsible for its renoprotective effects. The experiment divided male rats into four groups. Group 1 included untreated rats as the control. Group 2 included rats which received TAA (100 mg/kg intraperitoneally thrice a week for two weeks) to destroy their kidneys. Groups 3 and 4 included rats which received Pita orally at 0.4 and 0.8 mg/kg for 14 days after TAA injections. Renal injury increased BUN, creatinine, and MDA levels and decreased glutathione (GSH) levels. Pitavastatin prevented these alterations. TAA decreased PTEN and increased miR-93, Akt, p-Akt, mTOR, and Stat3 in the kidneys. Pitavastatin also regulated the associated culprit pathway, miR-93/PTEN/Akt/mTOR. In addition, TAA induced adverse effects on the kidney tissue, which were significantly ameliorated by pitavastatin treatment. The findings suggest that pitavastatin can attenuate renal injury, likely by regulating the miR-93/PTEN/Akt/mTOR pathway. This modulation of the pathway appears to contribute to the protective effects of pitavastatin against TAA-induced renal injury, adding to the growing evidence of the pleiotropic benefits of statins in renal health. |
format | Article |
id | doaj-art-d1493fa405fb43029a9c61767685786b |
institution | Kabale University |
issn | 2633-4690 |
language | English |
publishDate | 2024-01-01 |
publisher | Wiley |
record_format | Article |
series | Advances in Pharmacological and Pharmaceutical Sciences |
spelling | doaj-art-d1493fa405fb43029a9c61767685786b2025-02-03T01:29:46ZengWileyAdvances in Pharmacological and Pharmaceutical Sciences2633-46902024-01-01202410.1155/2024/6681873Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR PathwayMarawan A. Elbaset0Bassim M. S. A. Mohamed1Passant E. Moustafa2Tuba Esatbeyoglu3Sherif M. Afifi4Alyaa F. Hessin5Sahar S. Abdelrahman6Hany M. Fayed7Department of PharmacologyDepartment of PharmacologyDepartment of PharmacologyDepartment of Molecular Food Chemistry and Food DevelopmentPharmacognosy DepartmentDepartment of PharmacologyDepartment of PathologyDepartment of PharmacologyThis research investigated if pitavastatin (Pita) might protect rats’ kidneys against thioacetamide (TAA). By altering the PTEN/AKT/mTOR pathway, pitavastatin may boost kidney antioxidant capacity and minimize oxidative damage. Statins have several benefits, including antioxidant and anti-inflammatory characteristics. The principal hypothesis of this study was that Pita can regulate the miR-93/PTEN/AKT/mTOR pathways, which is thought to be responsible for its renoprotective effects. The experiment divided male rats into four groups. Group 1 included untreated rats as the control. Group 2 included rats which received TAA (100 mg/kg intraperitoneally thrice a week for two weeks) to destroy their kidneys. Groups 3 and 4 included rats which received Pita orally at 0.4 and 0.8 mg/kg for 14 days after TAA injections. Renal injury increased BUN, creatinine, and MDA levels and decreased glutathione (GSH) levels. Pitavastatin prevented these alterations. TAA decreased PTEN and increased miR-93, Akt, p-Akt, mTOR, and Stat3 in the kidneys. Pitavastatin also regulated the associated culprit pathway, miR-93/PTEN/Akt/mTOR. In addition, TAA induced adverse effects on the kidney tissue, which were significantly ameliorated by pitavastatin treatment. The findings suggest that pitavastatin can attenuate renal injury, likely by regulating the miR-93/PTEN/Akt/mTOR pathway. This modulation of the pathway appears to contribute to the protective effects of pitavastatin against TAA-induced renal injury, adding to the growing evidence of the pleiotropic benefits of statins in renal health.http://dx.doi.org/10.1155/2024/6681873 |
spellingShingle | Marawan A. Elbaset Bassim M. S. A. Mohamed Passant E. Moustafa Tuba Esatbeyoglu Sherif M. Afifi Alyaa F. Hessin Sahar S. Abdelrahman Hany M. Fayed Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway Advances in Pharmacological and Pharmaceutical Sciences |
title | Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway |
title_full | Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway |
title_fullStr | Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway |
title_full_unstemmed | Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway |
title_short | Renoprotective Effect of Pitavastatin against TAA-Induced Renal Injury: Involvement of the miR-93/PTEN/AKT/mTOR Pathway |
title_sort | renoprotective effect of pitavastatin against taa induced renal injury involvement of the mir 93 pten akt mtor pathway |
url | http://dx.doi.org/10.1155/2024/6681873 |
work_keys_str_mv | AT marawanaelbaset renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway AT bassimmsamohamed renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway AT passantemoustafa renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway AT tubaesatbeyoglu renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway AT sherifmafifi renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway AT alyaafhessin renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway AT saharsabdelrahman renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway AT hanymfayed renoprotectiveeffectofpitavastatinagainsttaainducedrenalinjuryinvolvementofthemir93ptenaktmtorpathway |